We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone figure if Eroxon sells well at Boots upon FDA the parent (biggest pharmacy group in the world) Walgreens (boots owner) might take an interest in the US ?
Well, we have been waiting a long time for this. very promising development imo.
So boots must be happy with initial sales and feedback to warrant spending money on Eroxon to further boost sales. They wouldn’t do this if they were unhappy about any aspects of the initial launch.
I saw it too. It was an advert for Boots featuring Eroxon. Good exposure.
Yes!!!
Maybe now is the time to buy more shares...?
OMG!!!! I have just seen an advert on TV for ERoxon following Tipping point on ITV
Amazing !!!!
Rpg7- Unfortunately, that is capitalism at it's best. GO must have had an insight to AIM when he wrote animal farm.
In my book there is only one thing worse than traders ,unfortunately it is unprintable . They destroy fledgling company value with their greed and will be responsible for the inevitable demise of the trading platform. Eventually there will be so few investors that the traders will be like rats in a sack.
Nice summary Chizzwizzy47 - thank you.
I've said it before that FUM has been a Traders dream with its peaks and troughs. Right now, I'm sure we're all surprised of the 20% plus fall since commercialisation started - but the sales we can see for ourselves that are happening right here in the UK , never mind those in Europe means money is going to stream into Futura. Remember the product is easily manufactured - I doubt it is expensive to produce and is selling at a crazy high sum which if it holds is going to be so lucrative.
Patience is certainly the name of the game for shareholders right now. GLA
Lack of news is keeping the share price low, let’s hope all the news comes at once & keeps the dodgy traders out! Us long term holders deserve that at least! Good luck all hope news is imminent! Or maybe the SP has been dropped to allow those traders in??
As long FUMsters will know, this has been a ride of patience...IMO marketing is low key currently pending FDA approval which will be the catalyst which may provide the green light for full marketing exposure, until that time, its trickled out & momentum slowly builds, people talk, the word spreads, people ask questions. But it is a patience game! I've said it before, this product will fly for the people that are responsive with it (60%) the negative reviews will not matter. Eroxon will find its place in the market. Eroxon is 'Safe' it holds all the key advantages to that of Viagra, mainly being No Side affects, OTC, No drug interaction, Boner within 10 mins, what's not to like!. Viagra had its issues back at the start, there were risks associated with its use, still is, heart warnings, medication interaction, many more etc...& look how it boomed with 1 billion dollars in its first year of sales. My point is even with the most severe of negativity with a product, it will always find its place in the market. I'm a passionate believer in this product & once it reaches the 'good responder audience' they will continue to buy time & time again. Yes marketing will boost this no doubt, & I think FDA & patient extension will be the lift-off point. IMO, let it gain some exposure, making sure that there are no ill affects not seen in patient trials, then approval comes! boom...TV ad's, campaigns, toilet wall posters, bill boards, the full shabang! but for investors wanting quick returns, this may not be for you. Although I think the time is near! Hold in there folks! any day now!!!
Looking over the past year NOT ONE MONTH has gone by without a few RNSs.May last year had 6!
we are expecting:
1.USA approval by end 2nd qyuater 2023 - just over a month to go.
2. A tax credit of £1.03 million.
3. Some concrete sales figures I would hane thought.
I reckon this will be kept low untill MMs can fill up prior to any of those annoncements and would imagine it could drop as low as the 30p range before.HOLD ON TIGHT
That would be that nutter liam booth. Believe as a past recreational user of viagra, and the likes it is not worth the headaches!
What’s needed is some quarterly sales figures and of course the FDA approval then some inferences about future direction will be clearer.
Keep the spirits up guys , we have been patient for this long ! Hoping for the US FDA approval to come soon , but at least in the meantime we have tangible product we can touch and on the market in distribution. I see negative reviews on Boots website and a lot of them end with "will stick to Viagra" which i find slightly interesting, it could just be the sceptic in me
I wish the seller would bugger off.
I was looking at Lombard's last two rns about notification of shares and it appears they sold almost 3 million which sent their holdings down by 1%. Wonder when they will advise if they've been selling more and how much lower their holdings will be (assuming it is Lombard that is selling).
Score on the sp door here in those 3 weeks will be the same. Dont do it to yourself, just catch your flight, spend those xtra minutes not in Boots to have another pre-flight spritzer.
Thats remined me. I am flying out of Stansted in 3 weeks will see what the score is at the Boots there.
Just passed through Gatwick. It was on top shelf with just one pack remaining. In the past week, the two boots who had it on bottom shelf have now transferred it to top.
Incidently, 'story of Viagra s1 e1' was aired on discovery Channel on Friday, an interesting watch, with input from Pizer's marketing men.
Many thanks HANRATTY, you have done us all a good turn - nothing like getting an unbiased opinion from the man at the coalface . Had hoped to be able to get an indication of sales at BOOTS GATWICK SOUTH TERMINAL last week but was running late and the place was a mad house but would hope that BOOTS will ensure plentiful supplies of EROXON at all airport branches with holiday demand in mind.
GLA Fumsters,ca
Arturo.
Spoke to one of the managers in my local Boots yesterday for a bit of realistic feedback, basically playing devil's advocate. I explained the situation with the online reviews and my natural scepticism. We had a bit of a chat regarding ED and the current products available to the public, he actually had recently returned from a Boots conference on ED products in England. He also mentioned that this product is indeed being sold in high volumes. Of course I qualified that, and asked him if he had noticed the same people returning to buy the product, because obviously you will have the initial novelty factor sales bump. He confirmed that yes there are plenty of returning customers. We also talked about the fact that of course it will not work for everyone, and that FUM never claimed that it would. I asked him about the age group of these returning customers, suggesting most of them must be in their 20's or 30's, not so apparently, young and old people are returning for this product.
to me fum needs to be successful with uk & european launch, otherwise fda approval is meaningless, as they will have proved they can’t organise a ****up in a brewery! let’s hope where all being a bit impatient & fum are in the ball!
I meant if the figures were poor/ below expectations. This will take years to fullly establish itself but once it does it will be a real monster.
Obtaining FDA approval ( it must be very close) is very likely although cannot be guaranteed so I am surprised how many traders sold out over the last few weeks especially after the product launch in Europe. They must be happy with their 10% or 20%. I sincerely hope that there is no leak and that we wake up to an RNS soon as this will lock a lot of traders out who will miss the rise which should be significant as the ability to launch in US will be transformative. I expect that funds will be keen to buy in on FDA news too. Much to look forward to.
Looks like its going up now.